RWB
LKFT

RMR Wealth Builders’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

RMR Wealth Builders’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-434
Closed -$33K – 364
2021
Q1 		$33K Hold
434
– – 0.01% 433
2020
Q4 		$43K Buy
+434
New +$53.1K 0.02% 272
2020
Q3 		– Sell
-396
Closed -$78K – 317
2020
Q2 		$78K Buy
+396
New +$82K 0.07% 189
2019
Q4 		$82K Buy
+396
New +$73.2K 0.08% 189

Other funds holding LKFT

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RMR Wealth Builders's LKFT Position: Q2 2021 in Review

RMR Wealth Builders sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2021, closing a stake of 434 shares — an estimated $33K sold.

RMR Wealth Builders first reported a position in LKFT in Q4 2019 and held it in 4 quarters. The position peaked at $82K in Q4 2019. 109 funds tracked by Wall St. Rank hold LKFT as of Q2 2021.

  • RMR Wealth Builders reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • RMR Wealth Builders sold 434 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2021, an estimated $33K.
  • RMR Wealth Builders first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2019 and held it in 4 quarters.
  • RMR Wealth Builders's Lakefront Biotherapeutics American Depositary Shares position peaked at $82K in Q4 2019.
  • 109 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2021.

Based on RMR Wealth Builders's 13F filing for Q2 2021, filed 16 Aug 2021.